The following stories appear in full on today's Vidyya Medical News Service Web site.
Guidelines for getting pregnant or avoiding pregnancy usually assume an average woman is fertile between days 10 and 17 of her menstrual cycle. But researchers at the National Institute of Environmental Health Sciences have demonstrated what some accidentally pregnant women may have long suspected: Only about 30 percent of women actually have their fertile window entirely within that timespan.
The National Center For Research Resources (NCRR) has developed a strategic plan to assist other National Institutes of Health Offices address the problem of health desparities among ethnic minorities in the US. NCRR creates, develops, and provides a comprehensive range of human, animal, technological, and other resources to enable biomedical research advances. The newest intiative is designed to expand and encourage clinical and basic research on diseases with health disparities for racial and ethnic minorities through enhanced clinical research among institutions within Institutional Development Award (IDeA)-eligible states. Read the NCRR's plan in today's issue.
The National Institutes of Allergy and Infectious Disease (NAID) seeks volunteers for a study of a vaccine to prevent shingles and to lessen the problems it causes.
The Patient Recruitment and Public Liaison Office (PRPL) is a service of the Warren Grant Magnuson Clinical Center at the National Institutes of Health (NIH). The NIH is one of the world's leading medical research facilities and the federal government's focal point for medical research in this country. PRPL staff members assist patients, their families, and physicians by providing information about participating in research being conducted at the Clinical Center, the NIH hospital in Bethesda, Maryland. Read about what which new studies seek volunteers.
The Food and Drug Administration announced that Christian Brothers Contracting Corporation and its President, Jason Vale, have signed a consent decree of permanent injunction in which it agreed to stop manufacturing, processing, and distributing its amygdalin products, also referred to as Laetrile, Vitamin B-17 or apricot kernels. The products were promoted for use in cancer therapy.
As always, we hope you enjoy the issue.